Bioactivity:

Hydroxypropyl-beta-cyclodextrin, also known as Hydroxypropyl-beta-cyclodextrin; THPB; HP-beta-CD; HPbCD; HP-beta-CyD; VTS-270; HPbetaCD; HPbetaCyD, is a drug candidate potentially for the treatment of Niemann-Pick type C diseases. In April 2009, hydroxypr

CAS nr:

107745-73-3

Purity:

98%

Molecular Weight:

1321,33

SMILES:

O[C@@H]1[C@H](O)[C@H](OC2[C@H](O)[C@H](O)[C@H]3[C@@H](COCC(O)C)O2)[C@@H](COCC(O)C)O[C@@H]1O[C@H]4[C@@H](O)[C@@H](O)C(O[C@H]5[C@@H](O)[C@@H](O)C(O[C@H]6[C@@H](O)[C@@H](O)[C@@H](O[C@H]7[C@@H](O)[C@@H](O)[C@@H](O3)O[C@@H]7COCC(O)C)O[C@@H]6COCC(O)C)O[C@@H]5COCC(O)C)O[C@@H]4COCC(O)C

Formula:

C54H96O36

Pathway:

Target: